Inventor · disambiguated record
Michael Powell
Also filed as: POWELL MICHAEL · POWELL MICHAEL J · POWELL MICHAEL JOHN
25 granted patents·11 pending applications·231 citations·filing 1991–2025
95Inventor score
Files withPOWELL MICHAEL J9POWELL MICHAEL6ACCESS TO DESIGN LTD3BOEHRINGER MANNHEIM CORP3COPPER CARE WOOD PRESERVATIVES INC2
Top patents by PatentIndex Score
36 records- 0194US7485298B2Diagnosis and treatment of human dormancy-related sequellaePOWELL MICHAEL·Filed 2005·Granted Feb 3, 2009·33 cites·21 claims
- 0292US8075902B2Diagnosis and treatment of cancer related to human dormancyPOWELL MICHAEL·Filed 2008·Granted Dec 13, 2011·14 cites·11 claims
- 0389US11274302B2Specific synthetic chimeric Xenonucleic acid guide RNA; s(XNA-gRNA) for enhancing CRISPR mediated genome editing efficiencyPOWELL MICHAEL J·Filed 2017·Granted Mar 15, 2022·4 cites·7 claims
- 0488US5646298ACyclopropylindole prodrugsPROCORON INC·Filed 1995·Granted Jul 8, 1997·58 cites·8 claims
- 0585US10400277B2DNA mutation detection employing enrichment of mutant polynucleotide sequences and minimally invasive samplingPOWELL MICHAEL J·Filed 2015·Granted Sep 3, 2019·3 cites·9 claims
- 0681US9435797B2Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulinSMITH BERNARD REES·Filed 2012·Granted Sep 6, 2016·4 cites·11 claims
- 0780US11208689B2DNA mutation detection employing enrichment of mutant polynucleotide sequences and minimally invasive samplingPOWELL MICHAEL J·Filed 2019·Granted Dec 28, 2021·3 cites·12 claims
- 0876US2024309373A1SPECIFIC SYNTHETIC CHIMERIC XENONUCLEIC ACID GUIDE RNA; s(XNA-gRNA) FOR ENHANCING CRISPR MEDIATED GENOME EDITING EFFICIENCYPOWELL MICHAEL J·Filed 2023·Application pending·0 cites
- 0976US2025303438A1Purgeable injection apparatus for spill-free replenishment of embedded foundation preservation wrapsCOPPER CARE WOOD PRESERVATIVES INC·Filed 2025·Application pending·0 cites
- 1075US2024301483A1Dna mutation detection employing enrichment of mutant polynucleotide sequences and minimally invasive samplingPOWELL MICHAEL J·Filed 2024·Application pending·0 cites
- 1174US12350707B2Purgeable injection apparatus for spill-free replenishment of embedded foundation preservation wrapsCOPPER CARE WOOD PRESERVATIVES INC·Filed 2023·Granted Jul 8, 2025·0 cites·25 claims
- 1272US8129132B2Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulinSMITH BERNARD REES·Filed 2002·Granted Mar 6, 2012·5 cites·6 claims
- 1372USD550071SAnchoring devicePOWELL BRENT KIRK·Filed 2005·Granted Sep 4, 2007·25 cites·1 claims
- 1468US2024076728A1NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTIONSUN QING·Filed 2023·Application pending·0 cites
- 1565US7288257B2Diagnosis and treatment of human dormancy syndromePOWELL MICHAEL·Filed 2003·Granted Oct 30, 2007·2 cites·6 claims
- 1663US9745633B2Detection of PNA clampingPOWELL MICHAEL J·Filed 2014·Granted Aug 29, 2017·0 cites·16 claims
- 1762US11845934B2Specific synthetic chimeric xenonucleic acid guide RNA; s(XNA-gRNA) for enhancing CRISPR mediated genome editing efficiencyPOWELL MICHAEL J·Filed 2019·Granted Dec 19, 2023·0 cites·1 claims
- 1860US2022025437A1NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTIONSUN QING·Filed 2021·Application pending·0 cites
- 1958US10488410B2Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulinRSR LTD·Filed 2016·Granted Nov 26, 2019·0 cites·29 claims
- 2057US10481156B2Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulinRSR LTD·Filed 2016·Granted Nov 19, 2019·0 cites·34 claims
- 2157US8343488B2Diagnosis and treatment of human dormancy-related sequellaePOWELL MICHAEL·Filed 2009·Granted Jan 1, 2013·0 cites·18 claims
- 2256US7648704B2Diagnosis and treatment of human dormancy syndromePOWELL MICHAEL·Filed 2007·Granted Jan 19, 2010·0 cites·11 claims
- 2356USD520343SAnchoring deviceACCESS TO DESIGN LTD·Filed 2003·Granted May 9, 2006·10 cites·1 claims
- 2455US6140137AConjugates and specific immunoassays for the methadone metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidineMICROGENICS CORP·Filed 1997·Granted Oct 31, 2000·19 cites·35 claims
- 2554US2022275450A1Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrencePOWELL MICHAEL J·Filed 2021·Application pending·0 cites
- 2652US5976857ACross-linked polypeptide fragments of β-galactosidaseBOEHRINGER MANNHEIM CORP·Filed 1996·Granted Nov 2, 1999·10 cites·24 claims
- 2752US2022025453A1Xenonucleic acid-mediated multiplex qpcr clamping technology for lung cancer mutation detectionSha michael y·Filed 2021·Application pending·0 cites
- 2847US5354410AApparatus for applying tape to a frame for glazingVENTURE TAPE CORP·Filed 1993·Granted Oct 11, 1994·23 cites·10 claims
- 2945US2005221302A1Tissue transglutaminasePOWELL MICHAEL·Filed 2002·Application pending·0 cites
- 3045US2018187267A1Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrencePOWELL MICHAEL J·Filed 2018·Application pending·0 cites
- 3143US2018355410A1Diagnosis and treatment of infectious diseaseCAMBRIDGE ENTPR LTD·Filed 2016·Application pending·0 cites
- 3241US5976783ABis-maleimido cross-linking agentsBOEHRINGER MANNHEIM CORP·Filed 1997·Granted Nov 2, 1999·3 cites·18 claims
- 3340US2006051183A1Ground anchorsACCESS TO DESIGN LTD·Filed 2005·Application pending·0 cites
- 3438US5155216ANucleic acids labeled with a chemiluminescent acridine esterAMOCO CORP·Filed 1991·Granted Oct 13, 1992·8 cites·11 claims
- 3536US5763196AAssays using cross-linked polypeptide fragments of β-galactosidaseBOEHRINGER MANNHEIM CORP·Filed 1996·Granted Jun 9, 1998·4 cites·20 claims
- 3632USD544340SAnchoring deviceACCESS TO DESIGN LTD·Filed 2004·Granted Jun 12, 2007·3 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Michael Powell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →